Profound Medical Corp. Insider Trading
TSX PRN
8
All Trades
2
Significant
6
Notable
5
Clusters
3
Repeat
Healthcare
Sector
Medical Devices
Industry
$340.1M
Market Cap
5.35 – 12.11
52 Week Range
19K
Avg. Volume
| Company | Insider | Title | Tr. Date | Fi. Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|---|
| Profound Medical | Tamberrino, Thomas | CCO | 17-Aug-26 | 17-Aug-26 | 53,573 | NT | ||||
| Profound Medical | Menawat, Dr. | Director | 20-Mar-26 | 20-Mar-26 | 658,660 | NT | ||||
| Profound Medical | Tamberrino, Thomas | CCO | 23-Dec-25 | 26-Dec-25 | 39,241 | SI CL | ||||
| Profound Medical | Rosenthal, Arthur | Director | 23-Dec-25 | 23-Dec-25 | 58,841 | SI CL | ||||
| Profound Medical | Rosenthal, Arthur | Director | 19-May-25 | 20-May-25 | 43,175 | NT RP | ||||
| Profound Medical | Rosenthal, Arthur | Director | 16-May-25 | 16-May-25 | 35,735 | NT CL RP | ||||
| Profound Medical | Rosenthal, Arthur | Director | 15-May-25 | 16-May-25 | 26,535 | NT CL RP | ||||
| Profound Medical | Tamberrino, Thomas | CCO | 15-May-25 | 16-May-25 | 25,333 | NT CL |
Profound Medical Corp. (PRN): Insider trading △ Insider buy
Volume (thousands)
Related Companies to Explore
Company Info
Profound Medical Corp. is a commercial-stage medical device company that develops and markets therapeutic systems using artificial intelligence and MRI guidance to ablate diseased tissue without incisions. The company operates in the healthcare sector within the medical devices industry.
Its primary product, the TULSA-PRO system, uses magnetic resonance imaging combined with robotically driven transurethral ultrasound and closed-loop temperature feedback to ablate prostate tissue, targeting either the whole gland or a physician-defined region, for the treatment of malignant or benign prostate conditions. The company also offers Sonalleve, a system that pairs real-time MRI with thermometry technology. Sonalleve is used to treat uterine fibroids, adenomyotic tissue, and osteoid osteoma, as well as for palliative pain treatment of bone metastases and management of benign tumors.
Profound Medical operates across several countries, including Canada, Germany, the United States, China, and Finland. The company is headquartered in Mississauga, Canada.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.